Your ears can’t text you a warning—they whisper. A new ringing, an extra ask of “sorry, say that again?,” a strange off‑balance moment. Sometimes, certain medications are the reason. The good news: you can often reduce risk with smart planning and simple monitoring—without stopping treatment you need. If you take (or may take) chemo, IV antibiotics, high‑dose pain relievers, or strong diuretics, this one’s for you.
Quick orientation: What is ototoxicity?
Ototoxicity means ear toxicity—damage to the inner ear (hearing and/or balance) from a drug. It most often shows up as high‑frequency hearing changes, tinnitus (ringing/buzzing), or dizziness/imbalance. Some effects are temporary, others can be permanent. Risk rises with higher doses, longer courses, kidney issues, combining multiple ototoxic drugs, and adding noise exposure on top.
If you’re about to start a known ototoxic medication, consider scheduling a baseline hearing check with an audiologist. It’s a simple, powerful way to catch changes early and adjust with your care team.
The usual suspects: Common ototoxic medications
Don’t stop a prescribed medication on your own. Instead, use this list to start a conversation with your prescriber or pharmacist about your personal risk and monitoring.
Higher‑concern categories
- Platinum chemotherapies: cisplatin (highest risk), carboplatin. Can cause permanent, high‑frequency sensorineural hearing loss and tinnitus. Children are especially vulnerable.
- Aminoglycoside antibiotics: gentamicin, tobramycin, amikacin, streptomycin. Risk of both hearing and balance problems, especially with kidney disease or when combined with other ototoxins.
- Loop diuretics: furosemide, bumetanide, ethacrynic acid. Risk rises with rapid IV pushes and high doses; often reversible when adjusted, but not always.
Moderate‑concern or situation‑specific
- Vancomycin: Ototoxic risk is usually low to moderate, higher when combined with aminoglycosides or in kidney impairment.
- Macrolides: erythromycin (especially high IV doses), azithromycin. Usually reversible hearing issues.
- High‑dose salicylates: aspirin in large doses. Often reversible tinnitus or muffled hearing once doses are reduced.
- Antimalarials/antirheumatics: quinine, chloroquine, hydroxychloroquine. Mostly reversible tinnitus/hearing changes.
- Ear drops with aminoglycosides: may pose risk if the eardrum is perforated or a tube is present—ask an ENT about safer alternatives.
Risk varies by person. Your kidneys, age, prior hearing status, and total “load” of ototoxic exposures matter. So does noise: a loud environment during treatment can magnify harm.
Make a prevention plan with your care team
You can be proactive without derailing treatment. Here’s a practical checklist to bring to your next appointment.
Before starting treatment
- Ask about risk upfront: “Is this medication ototoxic? What’s my personal risk based on dose, kidney function, and other meds?”
- Request a baseline hearing evaluation: Ask for an audiology referral. Ideal baseline includes conventional and high‑frequency audiometry (often up to 14–16 kHz) and otoacoustic emissions (OAEs). Keep a copy for your records.
- Review other exposures: List all meds and supplements. Flag any past tinnitus, hearing loss, or dizziness. Ask about avoiding simultaneous ototoxic combos when possible.
- Talk noise: Plan to reduce loud sound exposure (power tools, concerts, loud gyms) during and shortly after treatment. Keep ear protection handy.
- Plan follow‑up monitoring: Agree on how often to re‑test (e.g., before each chemo cycle or weekly during IV antibiotics) and what symptoms should trigger an urgent check.
During treatment
- Track your ears daily: Notice new ringing, fullness, muffled speech, or balance changes. A simple note in your phone works.
- Mind your kidneys and hydration: Kidney function influences ototoxicity risk. Follow fluid and lab guidance from your team.
- Ask about dosing details: Slow infusions (for loop diuretics) and monitoring drug levels (for aminoglycosides) can help reduce risk.
- Protect from noise: Carry earplugs. Double‑up protection (plugs + earmuffs) for short, very loud situations like yard tools or firing ranges.
- Report early changes: Tell your team promptly—small, early shifts can be easier to manage than big ones later.
After treatment
- Re‑check hearing: Schedule a post‑treatment hearing test, then periodic checks (e.g., 3–6 months) if you had changes or high exposure.
- Rehab if needed: If any hearing shift sticks around, talk with an audiologist about strategies, hearing technology, and tinnitus care.
Special situations worth knowing
Genetic sensitivity to aminoglycosides
A mitochondrial variant (often called MT‑RNR1 m.1555A>G) can make even a single aminoglycoside dose risky for profound hearing loss. It’s rare, but if you have a strong family history of sudden hearing loss after antibiotics, mention this to your clinician—genetic testing may be considered before non‑urgent use.
Pediatric ears are more vulnerable
Children on cisplatin have higher risk. In some pediatric cancers, oncologists may use sodium thiosulfate after cisplatin to reduce ototoxicity. Parents can ask, “Is ear protection like sodium thiosulfate appropriate in our case?” Decisions depend on cancer type and protocol.
Ear drops and perforations
If you have a hole in the eardrum or a tube, ask your ENT whether your drops contain aminoglycosides and if a non‑ototoxic alternative is better.
How hearing changes show up—and what to do
- Tinnitus: New ringing, buzzing, or high‑pitch tones. Action: log when it started, what changed (dose, new med, illness), reduce noise exposure, and call your care team. Ask for a prompt audiology re‑check.
- Speech sounds fuzzy or distant: Especially consonants like S, F, T. Action: seek a hearing test—high‑frequency losses often hide in everyday conversations.
- Balance feels off: Aminoglycosides can affect the vestibular system. Action: tell your team immediately. Lower‑light environments and quick head turns may feel worse; take extra fall‑prevention precautions until assessed.
Important: Don’t stop or change any medication without speaking to your prescriber. Many ototoxic effects can be reduced by adjusting dose, infusion rate, drug levels, timing, or by switching to an alternative—when appropriate for your condition.
Your “ear‑smart” conversation script
Steal these lines for your next appointment:
- “I read that this medicine can affect hearing. What’s my risk and how will we monitor it?”
- “Can we get a baseline hearing test with high‑frequency audiometry and OAEs before I start?”
- “If my hearing or balance changes, who should I call first, and how quickly can we check?”
- “Are there drug combinations or infusion rates we should avoid to lower risk?”
- “I work around noise—how should I protect my ears during treatment?”
Home tools: Helpful, not a substitute
App‑based hearing screeners and tinnitus trackers can help you notice changes, but they don’t replace professional testing. Use them to spot trends between official audiology visits.
Noise + drugs: The risky duet
Loud sound and ototoxic drugs can add up to more damage than either alone. While you’re on treatment—and for a few weeks after—treat your ears like VIPs:
- Keep volume down on headphones and earbuds.
- Wear ear protection during chores like mowing or leaf blowing.
- Skip very loud environments when you can; if you go, use well‑fitted plugs and limit time.
When the plan changes
Sometimes your team may shift a drug dose, stretch dosing intervals, adjust infusion speed, or choose an alternative antibiotic or chemo—if your hearing starts to change and if it’s safe for your underlying condition. That’s the point of monitoring: the earlier the nudge, the better the chance to protect your ears.
And if changes remain, an audiologist can help you rebound—tinnitus strategies, communication techniques, and when appropriate, hearing technology. Don’t wait to ask; early support makes life easier.
Bottom line
Medications save lives—and sometimes stress ears. With a baseline hearing test, ongoing check‑ins, and a few smart habits, you can catch problems early and often prevent bigger ones. If you’re starting any higher‑risk medication, consider calling an audiologist today to set your baseline.
FAQ
Further Reading
- Medicines Can Be Noisy: Preventing Drug‑Induced Hearing Loss and Tinnitus (Prevention) - Ear‑Safe Prescriptions: How to Spot and Prevent Drug‑Related Hearing Damage (Prevention) - Your Medicine, Your Ears: Preventing Drug‑Induced Hearing Loss (Hearing Loss) - When Noise Meets Chemicals: The Workplace Combo That Fast-Tracks Hearing Loss (Prevention)Frequently Asked Questions
Are drug‑related hearing changes reversible?
It depends on the medication and your situation. High‑dose salicylates and some macrolides often cause temporary shifts that improve when the drug is adjusted. Cisplatin and some aminoglycosides can cause permanent changes. Early monitoring gives your team more options to modify treatment if it’s safe to do so. Always talk to your prescriber before changing any medication.
Should I avoid all loud sounds while on an ototoxic medication?
You don’t have to live in silence, but it’s smart to reduce loud exposures. Keep headphone volume modest, wear hearing protection for power tools or concerts, and limit time in very loud places. Noise and ototoxic drugs can add up, so small protective steps matter.
Can supplements protect my hearing during chemotherapy or IV antibiotics?
There’s no over‑the‑counter supplement proven to reliably prevent ototoxicity across people and drugs. In specific pediatric oncology settings, sodium thiosulfate has been used under medical supervision to reduce cisplatin‑related hearing loss. Before starting any supplement, check with your oncology or infectious disease team to avoid interactions.
Is a single dose of an aminoglycoside dangerous?
For most people, a single dose carries low risk. However, individuals with certain mitochondrial variants (like MT‑RNR1 m.1555A>G) can be highly sensitive, and even one dose may cause severe hearing loss. If there’s a strong family history of sudden hearing loss after antibiotics, mention this to your clinician before non‑urgent use.